These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 8558777)

  • 1. Separation and analysis of glycyrrhizin, 18beta-glycyrrhetic acid and 18alpha-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis.
    Sabbioni C; Mandrioli R; Ferranti A; Bugamelli F; Saracino MA; Forti GC; Fanali S; Raggi MA
    J Chromatogr A; 2005 Jul; 1081(1):65-71. PubMed ID: 16013600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot synthesis of glycyrrhetic acid polyglycosides based on grafting-from method using cyclic sulfite.
    Shetty SS; Koyama Y
    Tetrahedron Lett; 2016 Aug; 57(32):3657-3661. PubMed ID: 32287447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.
    Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K
    J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin.
    Nagao Y; Sata M; Tanikawa K; Kameyama T
    Kansenshogaku Zasshi; 1995 Aug; 69(8):940-4. PubMed ID: 7594790
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic basis of glycyrrhizin on chronic hepatitis B.
    Sato H; Goto W; Yamamura J; Kurokawa M; Kageyama S; Takahara T; Watanabe A; Shiraki K
    Antiviral Res; 1996 May; 30(2-3):171-7. PubMed ID: 8783808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between pharmacokinetic behaviour of glycyrrhizin and hepatic function in patients with acute hepatitis and liver cirrhosis.
    Yamamura Y; Tanaka N; Santa T; Kotaki H; Aikawa T; Uchino K; Osuga T; Sawada Y; Iga T
    Biopharm Drug Dispos; 1995 Jan; 16(1):13-21. PubMed ID: 7711280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Aikawa T; Osuga T; Iga T
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
    Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.
    van Rossum TG; Vulto AG; de Man RA; Brouwer JT; Schalm SW
    Aliment Pharmacol Ther; 1998 Mar; 12(3):199-205. PubMed ID: 9570253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.
    Ploeger B; Mensinga T; Sips A; Seinen W; Meulenbelt J; DeJongh J
    Drug Metab Rev; 2001 May; 33(2):125-47. PubMed ID: 11495500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1994 Jul; 52(7):1823-7. PubMed ID: 8078202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid.
    Feng X; Ding L; Qiu F
    Drug Metab Rev; 2015 May; 47(2):229-38. PubMed ID: 25825801
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.